{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:14:10Z","timestamp":1794708850054,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18POST34030003"],"award-info":[{"award-number":["18POST34030003"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.amjcard.2021.04.023","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T19:51:16Z","timestamp":1623009076000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Triglyceride\u2013Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End\u2013Stage Renal Disease on Hemodialysis"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-4287","authenticated-orcid":false,"given":"Julio A.","family":"Lamprea\u2013Montealegre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-7469","authenticated-orcid":false,"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Scharnagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Silbernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-9707","authenticated-orcid":false,"given":"Christiane","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2021.04.023_bib0001","series-title":"2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","year":"2018"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0003","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0004","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo\u2013controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(12)80030-8","article-title":"Lipoprotein metabolism and renal failure","volume":"21","author":"Attman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0006","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM196807252790403","article-title":"Hypertriglyceridemia\u2014a metabolic consequence of chronic renal failure","volume":"279","author":"Bagdade","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa043545","article-title":"German diabetes and dialysis study investigators. atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0009","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1046\/j.1523-1755.1999.07158.x","article-title":"Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die deutsche diabetes dialysie studie investigators","volume":"71","author":"Wanner","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000080241","article-title":"Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics","volume":"27","author":"Wanner","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0011","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2215\/CJN.09121010","article-title":"Atorvastatin and low\u2013density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis","volume":"6","author":"M\u00e4rz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0012","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1681\/ASN.2013080816","article-title":"HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients","volume":"26","author":"Silbernagel","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0014","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.08730816","article-title":"Association of Serum Triglyceride to HDL cholesterol ratio with all\u2013cause and cardiovascular mortality in incident hemodialysis patients","volume":"12","author":"Chang","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/870608","article-title":"Ganti Stead L. The triglyceride paradox in stroke survivors: a prospective study","volume":"2013","author":"Jain","year":"2013","journal-title":"Neurosci J"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0016","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/ATVBAHA.112.300624","article-title":"Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence","volume":"33","author":"Lamprea\u2013Montealegre","year":"2013","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2017-312794","article-title":"Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease","author":"Lamprea\u2013Montealegre","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0018","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.07320619","article-title":"Apolipoprotein B, triglyceride\u2013rich lipoproteins, and risk of cardiovascular events in persons with CKD","volume":"15","author":"Lamprea\u2013Montealegre","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0020","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary\u2013artery calcification in young adults with end\u2013stage renal disease who are undergoing hemodialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0021","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0022","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ki.2014.187","article-title":"The clinical significance of medial arterial calcification in end\u2013stage renal disease in women","volume":"87","author":"Abou\u2013Hassan","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0024","first-page":"672","article-title":"Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nature Clinical Practice","volume":"4","author":"Kendrick","year":"2008","journal-title":"Nephrology"},{"key":"10.1016\/j.amjcard.2021.04.023_bib0025","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921003994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921003994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:20:00Z","timestamp":1777389600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914921003994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":25,"alternative-id":["S0002914921003994"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.04.023","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triglyceride\u2013Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End\u2013Stage Renal Disease on Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}